Pancreatic Cancer Research

ResearcherUniversität UlmNo recent work listed

Jan-Philipp Ruff

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5048906478. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death. Co-author DOI 10.21873/anticanres.15416↗
  2. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms19103219↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna-Laura Kretz · 2 shared papers, 2018–2021 · strength 0.24
  2. Johannes Lemke · 2 shared papers, 2018–2021 · strength 0.24
  3. Benno Traub · 1 shared paper, 2021 · strength 0.16
  4. Marko Kornmann · 1 shared paper, 2021 · strength 0.16
  5. Balbina García-Reyes · 1 shared paper, 2018 · strength 0.09
  6. Silvia von Karstedt · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.